Ovoca Gold plc (OVXA.IR)

0.0060 0.0000 (0.00%) At close: 08:00AM IST

Ovoca Gold plc

17 Pembroke Street Upper
D02 AT22
Dublin 2
Ireland
353 1 661 9819
https://ovocabio.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 5

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Kirill Andreyevich Golovanov	Interim Chairman of the Board & CEO	146k	N/A	1978
Mr. Dmitriy Nikitashenko	Vice President of Finance	N/A	N/A	N/A
Reneta Nikolova	Corporate Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for women health. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.

Corporate governance

Ovoca Gold plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.